Cargando…
Clinical Features of Lysosomal Acid Lipase Deficiency
OBJECTIVE: The aim of this study was to characterize key clinical manifestations of lysosomal acid lipase deficiency (LAL D) in children and adults. METHODS: Investigators reviewed medical records of LAL D patients ages ≥5 years, extracted historical data, and obtained prospective laboratory and ima...
Autores principales: | Burton, Barbara K., Deegan, Patrick B., Enns, Gregory M., Guardamagna, Ornella, Horslen, Simon, Hovingh, Gerard K., Lobritto, Steve J., Malinova, Vera, McLin, Valerie A., Raiman, Julian, Di Rocco, Maja, Santra, Saikat, Sharma, Reena, Sykut-Cegielska, Jolanta, Whitley, Chester B., Eckert, Stephen, Valayannopoulos, Vassili, Quinn, Anthony G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4645959/ https://www.ncbi.nlm.nih.gov/pubmed/26252914 http://dx.doi.org/10.1097/MPG.0000000000000935 |
Ejemplares similares
-
Rapid progression and mortality of lysosomal acid lipase deficiency presenting in infants
por: Jones, Simon A., et al.
Publicado: (2016) -
Sebelipase alfa for lysosomal acid lipase deficiency: 5‐year treatment experience from a phase 2 open‐label extension study
por: Malinová, Vĕra, et al.
Publicado: (2020) -
Survival in infants treated with sebelipase Alfa for lysosomal acid lipase deficiency: an open-label, multicenter, dose-escalation study
por: Jones, Simon A., et al.
Publicado: (2017) -
Lipases in lysosomes, what for?
por: Czaja, Mark J., et al.
Publicado: (2009) -
Cross-border healthcare? The Polish experience
por: Sykut-Cegielska, Jolanta
Publicado: (2010)